The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 30, 2023 | Howze Yalonda | See Remarks | Sell(S) | 2K | $0.20 | $326 |
| Mar 29, 2023 | Barna Nicole | See Remarks | Sell(S) | 5K | $0.17 | $913 |
| Mar 29, 2023 | Barna Nicole | See Remarks | Sell(S) | 2K | $0.17 | $328 |
| Mar 29, 2023 | Sathyanarayanan Sriram | Chief Scientific Officer | Sell(S) | 12K | $0.17 | $2K |
| Mar 28, 2023 | Williams Douglas E | President & CEO, Director | Sell(S) | 42K | $0.18 | $8K |
| Mar 28, 2023 | Bain Linda | Chief Financial Officer | Sell(S) | 13K | $0.17 | $2K |
| Mar 28, 2023 | Konstantinov Konstantin | Chief Technology Officer | Sell(S) | 7K | $0.20 | $1K |
| Mar 28, 2023 | Konstantinov Konstantin | Chief Technology Officer | Sell(S) | 2K | $0.20 | $386 |
| Feb 17, 2023 | Howze Yalonda | See Remarks | Sell(S) | 2K | $0.59 | $946 |
| Feb 17, 2023 | Barna Nicole | See Remarks | Sell(S) | 1K | $0.59 | $752 |
| Feb 17, 2023 | Sathyanarayanan Sriram | Chief Scientific Officer | Sell(S) | 2K | $0.59 | $1K |
| Feb 17, 2023 | Williams Douglas E | President & CEO, Director | Sell(S) | 8K | $0.59 | $5K |
| Feb 17, 2023 | Konstantinov Konstantin | Chief Technology Officer | Sell(S) | 1K | $0.59 | $821 |
| Feb 17, 2023 | Bain Linda | Chief Financial Officer | Sell(S) | 3K | $0.59 | $2K |
| Feb 16, 2023 | Howze Yalonda | See Remarks | Option exercise(M) | 5K | — | — |
| Feb 16, 2023 | Howze Yalonda | See Remarks | Option exercise(M) | 5K | — | $0 |
| Feb 16, 2023 | Melas Kyriazi Theo | Director | Option exercise(M) | 9K | — | — |
| Feb 16, 2023 | Melas Kyriazi Theo | Director | Option exercise(M) | 9K | — | $0 |
| Feb 16, 2023 | Barna Nicole | See Remarks | Option exercise(M) | 3K | — | — |
| Feb 16, 2023 | Barna Nicole | See Remarks | Option exercise(M) | 3K | — | $0 |
| Feb 16, 2023 | Cooney Charles L | Director | Option exercise(M) | 9K | — | — |
| Feb 16, 2023 | Cooney Charles L | Director | Option exercise(M) | 9K | — | $0 |
| Feb 16, 2023 | Gillis Steven | Director | Option exercise(M) | 9K | — | — |
| Feb 16, 2023 | Gillis Steven | Director | Option exercise(M) | 9K | — | $0 |
| Feb 16, 2023 | Haddock Jason | Director | Option exercise(M) | 9K | — | — |
| Feb 16, 2023 | Haddock Jason | Director | Option exercise(M) | 9K | — | $0 |
| Feb 16, 2023 | Bernstein Karen | Director | Option exercise(M) | 9K | — | — |
| Feb 16, 2023 | Bernstein Karen | Director | Option exercise(M) | 9K | — | $0 |
| Feb 16, 2023 | Sathyanarayanan Sriram | Chief Scientific Officer | Option exercise(M) | 7K | — | — |
| Feb 16, 2023 | Sathyanarayanan Sriram | Chief Scientific Officer | Option exercise(M) | 7K | — | $0 |
| Feb 16, 2023 | Williams Douglas E | President & CEO, Director | Option exercise(M) | 23K | — | — |
| Feb 16, 2023 | Williams Douglas E | President & CEO, Director | Option exercise(M) | 23K | — | $0 |
| Feb 16, 2023 | Konstantinov Konstantin | Chief Technology Officer | Option exercise(M) | 4K | — | — |
| Feb 16, 2023 | Konstantinov Konstantin | Chief Technology Officer | Option exercise(M) | 4K | — | $0 |
| Feb 16, 2023 | Bain Linda | Chief Financial Officer | Option exercise(M) | 8K | — | — |
| Feb 16, 2023 | Bain Linda | Chief Financial Officer | Option exercise(M) | 8K | — | $0 |
| Jan 24, 2023 | Barna Nicole | See Remarks | Grant(A) | 105K | — | $0 |
| Jan 24, 2023 | Williams Douglas E | President & CEO, Director | Grant(A) | 465K | — | $0 |
| Jan 24, 2023 | Howze Yalonda | See Remarks | Grant(A) | 150K | — | $0 |
| Jan 24, 2023 | Bain Linda | Chief Financial Officer | Grant(A) | 185K | — | $0 |
| Jan 24, 2023 | Konstantinov Konstantin | Chief Technology Officer | Grant(A) | 145K | — | $0 |
| Jan 24, 2023 | Sathyanarayanan Sriram | Chief Scientific Officer | Grant(A) | 140K | — | $0 |
| Jan 24, 2023 | Mauro David J | Chief Medical Officer | Grant(A) | 190K | — | $0 |
| Jan 20, 2023 | Barna Nicole | See Remarks | Sell(S) | 836 | $0.58 | $485 |
| Jan 20, 2023 | Howze Yalonda | See Remarks | Sell(S) | 2K | $0.58 | $877 |
| Jan 20, 2023 | Williams Douglas E | See Remarks, Director | Sell(S) | 5K | $0.58 | $3K |
| Jan 20, 2023 | Sathyanarayanan Sriram | Chief Scientific Officer | Sell(S) | 1K | $0.58 | $628 |
| Jan 20, 2023 | Konstantinov Konstantin | Chief Technology Officer | Sell(S) | 1K | $0.58 | $620 |
| Jan 20, 2023 | Bain Linda | Chief Financial Officer | Sell(S) | 2K | $0.58 | $1K |
| Jan 19, 2023 | Barna Nicole | See Remarks | Option exercise(M) | 2K | — | — |
| Jan 19, 2023 | Barna Nicole | See Remarks | Option exercise(M) | 2K | — | $0 |
| Jan 19, 2023 | Howze Yalonda | See Remarks | Option exercise(M) | 4K | — | — |
| Jan 19, 2023 | Howze Yalonda | See Remarks | Option exercise(M) | 4K | — | $0 |
| Jan 19, 2023 | Williams Douglas E | See Remarks, Director | Option exercise(M) | 14K | — | — |
| Jan 19, 2023 | Williams Douglas E | See Remarks, Director | Option exercise(M) | 14K | — | $0 |
| Jan 19, 2023 | Sathyanarayanan Sriram | Chief Scientific Officer | Option exercise(M) | 3K | — | — |
| Jan 19, 2023 | Sathyanarayanan Sriram | Chief Scientific Officer | Option exercise(M) | 3K | — | $0 |
| Jan 19, 2023 | Konstantinov Konstantin | Chief Technology Officer | Option exercise(M) | 3K | — | — |
| Jan 19, 2023 | Konstantinov Konstantin | Chief Technology Officer | Option exercise(M) | 3K | — | $0 |
| Jan 19, 2023 | Bain Linda | Chief Financial Officer | Option exercise(M) | 5K | — | — |
| Jan 19, 2023 | Bain Linda | Chief Financial Officer | Option exercise(M) | 5K | — | $0 |
| Sep 16, 2022 | Howze Yalonda | See Remarks | Grant(A) | 80K | — | $0 |
| Sep 16, 2022 | Konstantinov Konstantin | Chief Technology Officer | Grant(A) | 80K | — | $0 |
| Sep 16, 2022 | Mauro David J | Chief Medical Officer | Grant(A) | 80K | — | $0 |
| Sep 16, 2022 | Bain Linda | Chief Financial Officer | Grant(A) | 80K | — | $0 |
| Sep 16, 2022 | Sathyanarayanan Sriram | Chief Scientific Officer | Grant(A) | 80K | — | $0 |
| Sep 15, 2022 | Flagship V VentureLabs Rx Fund, L.P. | 10% Owner | Buy(P) | 723K | — | — |
| Sep 15, 2022 | Flagship V VentureLabs Rx Fund, L.P. | 10% Owner | Buy(P) | 211K | — | — |
| Sep 15, 2022 | Flagship V VentureLabs Rx Fund, L.P. | 10% Owner | Buy(P) | 211K | — | — |
| Sep 15, 2022 | Flagship V VentureLabs Rx Fund, L.P. | 10% Owner | Buy(P) | 723K | — | — |
| Sep 13, 2022 | ARCH Venture Fund VIII Overage, L.P. | 10% Owner | Buy(P) | 5.0M | $1.50 | $7.5M |
| Sep 13, 2022 | ARCH Venture Fund VIII Overage, L.P. | 10% Owner | Buy(P) | 5.0M | — | — |
| Sep 13, 2022 | Gillis Steven | Director | Buy(P) | 5.0M | — | — |
| Sep 13, 2022 | Gillis Steven | Director | Buy(P) | 5.0M | — | — |
| Aug 17, 2022 | Howze Yalonda | See Remarks | Sell(S) | 2K | $2.21 | $3K |
| Aug 17, 2022 | Barna Nicole | See Remarks | Sell(S) | 984 | $2.21 | $2K |
| Aug 17, 2022 | Sathyanarayanan Sriram | Chief Scientific Officer | Sell(S) | 2K | $2.21 | $5K |
| Aug 17, 2022 | Williams Douglas E | President & CEO, Director | Sell(S) | 7K | $2.21 | $16K |
| Aug 17, 2022 | Konstantinov Konstantin | Chief Technology Officer | Sell(S) | 1K | $2.21 | $3K |
| Aug 17, 2022 | Bain Linda | Chief Financial Officer | Sell(S) | 2K | $2.21 | $5K |
| Aug 16, 2022 | Howze Yalonda | See Remarks | Option exercise(M) | 5K | — | — |
| Aug 16, 2022 | Howze Yalonda | See Remarks | Option exercise(M) | 5K | — | $0 |
| Aug 16, 2022 | Barna Nicole | See Remarks | Option exercise(M) | 3K | — | — |
| Aug 16, 2022 | Barna Nicole | See Remarks | Option exercise(M) | 3K | — | $0 |
| Aug 16, 2022 | Sathyanarayanan Sriram | Chief Scientific Officer | Option exercise(M) | 7K | — | — |
| Aug 16, 2022 | Sathyanarayanan Sriram | Chief Scientific Officer | Option exercise(M) | 7K | — | $0 |
| Aug 16, 2022 | Williams Douglas E | President & CEO, Director | Option exercise(M) | 23K | — | — |
| Aug 16, 2022 | Williams Douglas E | President & CEO, Director | Option exercise(M) | 23K | — | $0 |
| Aug 16, 2022 | Konstantinov Konstantin | Chief Technology Officer | Option exercise(M) | 4K | — | — |
| Aug 16, 2022 | Konstantinov Konstantin | Chief Technology Officer | Option exercise(M) | 4K | — | $0 |
| Aug 16, 2022 | Bain Linda | Chief Financial Officer | Option exercise(M) | 8K | — | — |
| Aug 16, 2022 | Bain Linda | Chief Financial Officer | Option exercise(M) | 8K | — | $0 |
| Jun 17, 2022 | Pandite Arundathy N. | Director | Grant(A) | 2K | — | $0 |
| Jun 17, 2022 | Pandite Arundathy N. | Director | Grant(A) | 8K | — | $0 |
| Jun 17, 2022 | Gillis Steven | Director | Grant(A) | 2K | — | $0 |
| Jun 17, 2022 | Gillis Steven | Director | Grant(A) | 8K | — | $0 |
| Jun 17, 2022 | Cooney Charles L | Director | Grant(A) | 2K | — | $0 |
| Jun 17, 2022 | Cooney Charles L | Director | Grant(A) | 8K | — | $0 |
| Jun 17, 2022 | Melas Kyriazi Theo | Director | Grant(A) | 2K | — | $0 |
| Jun 17, 2022 | Melas Kyriazi Theo | Director | Grant(A) | 8K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).